Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Helms

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Annals of Intensive Care|February 13, 2020
Influence of deprivation on initial severity and prognosis of patients admitted to the ICU: the prospective, multicentre, observational IVOIRE cohort studyJean-Pierre Quenot, Julie Helms, Guylaine Labro, et al.
Annals of Intensive Care|July 3, 2019
Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trialJean-Pierre Quenot, Julie Helms, Abderrahmane Bourredjem, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2023
Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and HemostasisJerrold H Levy, Roman M Sniecinski, Bianca Rocca, et al.
Viruses|May 28, 2022
Evolution of Neuroimaging Findings in Severe COVID-19 Patients with Initial Neurological Impairment: An Observational StudyFrançois Lersy, Caroline Bund, Mathieu Anheim, et al.
Critical Care (London, England)|June 19, 2026
Timing matters: sex differences in treatment limitation decisions in intensive careSimon A Amacher, Pimrapat Gebert, Valentina Tröster, et al.
Eclinicalmedicine|June 23, 2023
Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trialBruno François, Simon Lambden, Jean-Jacques Garaud, et al.
JAMA|February 1, 2022
Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical TrialBruno Levy, Nicolas Girerd, Julien Amour, et al.
Angiogenesis|June 29, 2021
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspectsDavid M Smadja, Steven J Mentzer, Michaela Fontenay, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
Intensive Care Medicine|August 24, 2018
Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide studyAntoine Kimmoun, Walid Oulehri, Romain Sonneville, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Annals of Intensive Care|February 13, 2020
Influence of deprivation on initial severity and prognosis of patients admitted to the ICU: the prospective, multicentre, observational IVOIRE cohort studyJean-Pierre Quenot, Julie Helms, Guylaine Labro, et al.
Annals of Intensive Care|July 3, 2019
Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trialJean-Pierre Quenot, Julie Helms, Abderrahmane Bourredjem, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2023
Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and HemostasisJerrold H Levy, Roman M Sniecinski, Bianca Rocca, et al.
Viruses|May 28, 2022
Evolution of Neuroimaging Findings in Severe COVID-19 Patients with Initial Neurological Impairment: An Observational StudyFrançois Lersy, Caroline Bund, Mathieu Anheim, et al.
Critical Care (London, England)|June 19, 2026
Timing matters: sex differences in treatment limitation decisions in intensive careSimon A Amacher, Pimrapat Gebert, Valentina Tröster, et al.
Eclinicalmedicine|June 23, 2023
Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trialBruno François, Simon Lambden, Jean-Jacques Garaud, et al.
JAMA|February 1, 2022
Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical TrialBruno Levy, Nicolas Girerd, Julien Amour, et al.
Angiogenesis|June 29, 2021
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspectsDavid M Smadja, Steven J Mentzer, Michaela Fontenay, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
Intensive Care Medicine|August 24, 2018
Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide studyAntoine Kimmoun, Walid Oulehri, Romain Sonneville, et al.
Pageof 14